Latest filing published 17 Mar 2023 for Treace Medical Concepts, INC., €1.1M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Thomas e. Timbie in Treace Medical Concepts, Inc., where the filings describe the role as senior executive. In total, 11 filings cover trades dated from 7 September 2021 to 15 March 2023.
Every open-market trade on record is a sale: 8 sales worth €9.0M. Outside the open market, there are 1 share grant. Since January 2023: no purchases and 3 sales on the market.
On 17 March 2023 came the latest disclosure, an open-market sale for €1.1M in Treace Medical Concepts, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations